Sort
16,300 grants matching “fatty liver disease”
Living Donor Liver Transplant :Short & Long-Term Impact on Donors and Recipients
$226,615Chris Freise · University Of California, San Francisco · U01 · FY2012 · DK
NLRP3 Inflammasome Activation and Mitochondrial Function in the setting of Aging and HIV Infection
$226,556Heidi J Zapata · Yale University · K76 · FY2022 · AG
The dsRNA-activated Protein Kinase PKR in the Pathogenesis of Hyperlipidemia and
$226,500Qiaozhu Su · University Of Nebraska Lincoln · P20 · FY2016 · GM
Impact of the Intestinal Microbiota on the Host Epigenome and Obesity Phenotype
$226,500Amanda Ellen Ramer-Tait · University Of Nebraska Lincoln · P20 · FY2014 · GM
The dsRNA-activated Protein Kinase PKR in the Pathogenesis of Hyperlipidemia and
$226,500Qiaozhu Su · University Of Nebraska Lincoln · P20 · FY2014 · GM
Superfund Chemicals, Nutrition, and Multi-Organ Cardiovascular Risk
$226,500Bernhard Hennig · University Of Kentucky · P42 · FY2020 · ES
The dsRNA-activated Protein Kinase PKR in the Pathogenesis of Hyperlipidemia and
$226,500Qiaozhu Su · University Of Nebraska Lincoln · P20 · FY2017 · GM
Vascular PPAR alpha and atherosclerosis
$226,500Jayme Borensztajn · Northwestern University At Chicago · R21 · FY2008 · HL
Project 4: Impact of the Gut Microbiome on Liver Innate Immunity and Skeletal Function
$226,485Chad Michael Novince · Medical University Of South Carolina · P20 · FY2022 · GM
Community Engagement Core
$226,450Dwayne Edward Porter · University Of South Carolina At Columbia · P01 · FY2020 · ES
Etiologic Studies of Diet and Cancer
$226,434Christian Abnet · Division Of Cancer Epidemiology And Genetics · ZIA · FY2025 · CA
Progression from steatosis to steatohepatitis in alcoholic liver disease is enhanced by the risk allele of PNPLA3 via remodeling of lipid droplets and disruption of bioactive lipid composition
$226,406Paulina M Ordonez Naranjo · University Of California, San Diego · R21 · FY2020 · AA
Integrated molecular epidemiologic analysis of the one-carbon metabolism pathway and risk of HCC
$226,256Samuel O. Antwi · Mayo Clinic Jacksonville · K01 · FY2023 · CA
Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT-IU)
$226,211David W Crabb · Indiana University Indianapolis · U01 · FY2017 · AA
Glycocalyx in Pregnancy and the Preeclampsia Syndrome
$226,211Robin E Gandley · Magee-Women'S Res Inst And Foundation · R21 · FY2016 · HD
Neuroprotective Engineered Bacteria for Alzheimer's Disease Treatment
$226,189Arianna Miano · Bloom Science, Inc. · R43 · FY2025 · AG
Adipose and Fatty Liver in the Metabolic Syndrome
$226,182Jeffrey B Schwimmer · University Of California, San Diego · R21 · FY2006 · DK
Metabolic Control of Brucellosis
$226,179Jerod Skyberg · University Of Missouri-Columbia · R21 · FY2020 · AI
Role of PPARalpha and L-FABP in Acute Renal Failure
$226,074Didier Portilla · Univ Of Arkansas For Med Scis · R01 · FY2007 · DK
Developing Contrast-Enhanced Ultrasound of Thrombosis via SPIO-RL Platelets
$225,831Amy L Oldenburg · Univ Of North Carolina Chapel Hill · R21 · FY2014 · HL
THE EVOLUTION OF PGD ADDICTION IN HUMAN PANCREATIC CANCER
$225,786Oliver Gene McDonald · University Of Miami School Of Medicine · R01 · FY2024 · CA
Chromium treatment of Obesity-related insulin resistance
$225,758Dennis C Mynarcik · State University New York Stony Brook · R21 · FY2007 · AT
Palmitoleate Protects against Cholangiocyte Lipoapoptosis
$225,750Justin L. Mott · University Of Nebraska Lincoln · P20 · FY2018 · GM
Longitudinal Change in Obesity during Childhood and Adult Cardiometabolic Risk
$225,750Shengxu Li · Tulane University Of Louisiana · P20 · FY2016 · GM
Palmitoleate Protects against Cholangiocyte Lipoapoptosis
$225,750Justin L. Mott · University Of Nebraska Lincoln · P20 · FY2017 · GM